453 related articles for article (PubMed ID: 17878099)
1. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy for head and neck squamous cell carcinoma].
Bron L; Romero P
Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells and HNSCC: a potential treatment option? (Review).
Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
[TBL] [Abstract][Full Text] [Related]
5. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
Ferris RL
ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
[TBL] [Abstract][Full Text] [Related]
6. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Weise JB; Maune S; Görögh T; Kabelitz D; Arnold N; Pfisterer J; Hilpert F; Heiser A
Auris Nasus Larynx; 2004 Jun; 31(2):149-53. PubMed ID: 15121224
[TBL] [Abstract][Full Text] [Related]
7. [Future Prospects on neoplasm antigen vaccine therapy for patients with head and neck squamous cell carcinoma].
Eura M
Nihon Jibiinkoka Gakkai Kaiho; 2002 Mar; 105(3):201-7. PubMed ID: 12014346
[No Abstract] [Full Text] [Related]
8. Cytokines in head and neck cancer.
Pries R; Wollenberg B
Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
[TBL] [Abstract][Full Text] [Related]
9. Immune alterations and immunotherapy prospects in head and neck cancer.
Varilla V; Atienza J; Dasanu CA
Expert Opin Biol Ther; 2013 Sep; 13(9):1241-56. PubMed ID: 23789839
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
11. Immunology of head and neck cancers.
Newbill ET; Johns ME
Crit Rev Clin Lab Sci; 1983; 19(1):1-25. PubMed ID: 6201320
[TBL] [Abstract][Full Text] [Related]
12. Novel Treatment Options in Head and Neck Cancer.
Schuler PJ; Laban S; Doescher J; Bullinger L; Hoffmann TK
Oncol Res Treat; 2017; 40(6):342-346. PubMed ID: 28521322
[TBL] [Abstract][Full Text] [Related]
13. Transference of cell mediated immunity in patients with head and neck cancer.
Vetto RM; Burger DR
Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
[TBL] [Abstract][Full Text] [Related]
14. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
Cavalieri S; Rivoltini L; Bergamini C; Locati LD; Licitra L; Bossi P
Cancer Treat Rev; 2018 Apr; 65():78-86. PubMed ID: 29574334
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck.
Michaluart P; Abdallah KA; Lima FD; Smith R; Moysés RA; Coelho V; Victora GD; Socorro-Silva A; Volsi EC; Zárate-Bladés CR; Ferraz AR; Barreto AK; Chammas MC; Gomes R; Gebrim E; Arakawa-Sugueno L; Fernandes KP; Lotufo PA; Cardoso MR; Kalil J; Silva CL
Cancer Gene Ther; 2008 Oct; 15(10):676-84. PubMed ID: 18535616
[TBL] [Abstract][Full Text] [Related]
16. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
Hollinshead AC
Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
[TBL] [Abstract][Full Text] [Related]
17. Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.
Mayer A; Andratschke M; Pauli C; Graefe H; Kristina K; Wollenberg B
Anticancer Res; 2005; 25(6B):4075-80. PubMed ID: 16309201
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.
Moy JD; Moskovitz JM; Ferris RL
Eur J Cancer; 2017 May; 76():152-166. PubMed ID: 28324750
[TBL] [Abstract][Full Text] [Related]
19. Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients.
Victora GD; Socorro-Silva A; Volsi EC; Abdallah K; Lima FD; Smith RB; Moyses RA; Zárate-Bladés CR; Michaluart P; Silva CL; Kalil J; Coelho V
Cancer Gene Ther; 2009 Jul; 16(7):598-608. PubMed ID: 19197326
[TBL] [Abstract][Full Text] [Related]
20. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]